VeriCLIA – Fully Automated CLIA Analyzer

Product Overview:

High-throughput chemiluminescent immunoassay system for comprehensive diagnostic panels

VeriCLIA is Universal Prognostics’ flagship fully-automated chemiluminescent immunoassay (CLIA) platform, delivering up to 200 tests per hour with walk-away automation and rapid turnaround time. Powered by an advanced enzymatic or direct chemiluminescence principle, the analyzer supports a broad test menu covering endocrinology, fertility, oncology, cardiology, infectious diseases, inflammatory markers, and prenatal screening. It is optimized for central labs, hospital settings, and specialty clinics requiring reliable high-throughput performance with full traceability and integrated auto-QC.

Key Features:

High throughput: Up to 200 tests/hour, first result in ≤15 minutes
3-hour walk-away capacity with automated sample and reagent handling
Supports serum, plasma, and urine samples with volumes as low as 10 µL
Multi-barcode support, liquid level detection, clot and bubble sensing
Smart automation: auto-dilution, QC management, reagent tracking
HL7/NPHIES-compatible for seamless LIS integration

Technical Specifications:

Principle: Enzymatic or direct CLIA
Throughput: Up to 200 tests/hour
Sample Types: Serum, plasma, urine
Sample Volume: 10–150 µL
Carryover: < 10 ppm
Barcode Support: Multiple formats
Walk-away Time: 3 hours
Sample Capacity: 60 positions
Probe: Single steel probe with clot, bubble & level detection